Shuhei Fukuno

4PUBLICATIONS
4CO-AUTHORS
Biologically active moleculesEpidemiological modellingCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Aug 28, 2023
Danazol increases the oral bioavailability of midazolam by inactivation of hepatic and intestinal CYP3A in rats.

Shuhei Fukuno, Katsuhito Nagai, Akemi Kurotobi

|Dec 19, 2021
Doxorubicin alters the disposition of phenytoin by reducing its metabolic elimination and binding affinity to serum albumin in rats.

Shuhei Fukuno, Katsuhito Nagai, Shizuka Yamaoka

|Jun 20, 2019
Pharmacokinetic interference of doxorubicin with tolbutamide due to reduced metabolic clearance with increased serum unbound fraction in rats.

Shuhei Fukuno, Katsuhito Nagai, Kohei Yamamoto

|Jul 07, 2018
Pharmacokinetics and metabolic elimination of tolbutamide in female rats: Comparison with male rats.

Shuhei Fukuno, Katsuhito Nagai, Ayano Horii

Pageof 1